-
Optimizing medical and lifestyle change therapy rather than performing PCI is appropriate as the initial management strategy for most patients with known CAD who do not have unstable or disabling symptoms.
-
-
A randomized controlled trial in the Netherlands showed that oral prednisolone and naproxen were equivalent in the treatment of acute gout with no difference in side effects.
-
Using blood pressure, BUN, serum sodium, and presence of peripheral arterial disease as predictors of mortality in heart failure patients, 67% who had 3 or more factors died within 6 months and would qualify for the Medicare hospice benefit.
-
There are no disease-modifying pharmacotherapies for COPD. That is, although bronchodilators, anticholinergic agents, and inhaled corticosteroids improve FEV1 and reduce symptoms, decline in pulmonary function continues unabated and lung function returns promptly to pretreatment status once medication is stopped.
-
Whereas its potential benefits remain uncertain, prostate-specific antigen (PSA) screening may be associated with psychological harms. There has been a recent update to the screening guidelines by the U.S. Preventive Services Task Force (USPSTF).
-
A very large prospective study found no evidence that nuts, corn, popcorn, or seeds increased diverticular disease or its complications.
-
A randomized controlled trial of newly diagnosed type 2 diabetic patients not on insulin showed an increased depression score in those performing home glucose monitoring and no improvement in glycemic control.
-
A short-acting dihydropyridine calcium channel blocker with a rapid onset of action has been approved for intravenous use to reduce blood pressure.
-
The established causal relationship between endothelial dysfunction and erectile dysfunction (ED) provides mechanistic insight into an obesity-sexual health linkage.
